National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

Article  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, Shepherd FA. Non-small-cell lung cancer. Lancet. 2011;378(9804):1727–40.

Article  PubMed  Google Scholar 

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71–96.

Article  PubMed  Google Scholar 

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

Article  PubMed  Google Scholar 

Johnson DH, Schiller JH, Bunn PA Jr. Recent clinical advances in lung cancer management. J Clin Oncol. 2014;32(10):973–82.

Article  PubMed  CAS  Google Scholar 

Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol. 2013;14(7):e270–4.

Article  PubMed  Google Scholar 

Li G, Xue M, Chen W, Yi S. Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis. Eur J Radiol. 2018;100:92–8.

Article  PubMed  Google Scholar 

Berzenji L, Van Schil PE. Surgery or stereotactic body radiotherapy for early-stage lung cancer: two sides of the same coin? Eur Respir J. 2019;53(6):1900711.

Article  PubMed  Google Scholar 

Asamura H. Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? J Thorac Oncol. 2006;1(8):766–7.

Article  PubMed  Google Scholar 

Videtic GMM, Reddy CA, Woody NM, Stephans KL. Ten-year experience in implementing single-fraction lung SBRT for medically inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys. 2021;111(2):436–42.

Article  PubMed  Google Scholar 

The Lancet Respiratory M. Lung cancer—moving in the right direction. Lancet Respir Med. 2017;5(8):599.

Article  Google Scholar 

Tandberg DJ, Tong BC, Ackerson BG, Kelsey CR. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: a comprehensive review. Cancer. 2018;124(4):667–78.

Article  PubMed  Google Scholar 

Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg. 2018;153(6):588–9.

Article  PubMed  Google Scholar 

Sui Q, Liang J, Hu Z, Chen Z, Bi G, Huang Y, Li M, Zhan C, Lin Z, Wang Q. Genetic and microenvironmental differences in non-smoking lung adenocarcinoma patients compared with smoking patients. Transl Lung Cancer Res. 2020;9(4):1407–21.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xi J, Du Y, Hu Z, Liang J, Bian Y, Chen Z, Sui Q, Zhan C, Li M, Guo W. Long-term outcomes following neoadjuvant or adjuvant chemoradiotherapy for stage I-IIIA non-small cell lung cancer: a propensity-matched analysis. J Thorac Dis. 2020;12(6):3043–56.

Article  PubMed  PubMed Central  Google Scholar 

Jin X, Zheng Y, Chen Z, Wang F, Bi G, Li M, Liang J, Sui Q, Bian Y, Hu Z, et al. Integrated analysis of patients with KEAP1/NFE2L2/CUL3 mutations in lung adenocarcinomas. Cancer Med. 2021;10(23):8673–92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shah A, Hahn SM, Stetson RL, Friedberg JS, Pechet TT, Sher DJ. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. Cancer. 2013;119(17):3123–32.

Article  PubMed  Google Scholar 

Crabtree TD, Denlinger CE, Meyers BF, El Naqa I, Zoole J, Krupnick AS, Kreisel D, Patterson GA, Bradley JD. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010;140(2):377–86.

Article  PubMed  Google Scholar 

Verstegen NE, Oosterhuis JW, Palma DA, Rodrigues G, Lagerwaard FJ, van der Elst A, Mollema R, van Tets WF, Warner A, Joosten JJ, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol. 2013;24(6):1543–8.

Article  PubMed  CAS  Google Scholar 

Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shinde A, Li R, Kim J, Salgia R, Hurria A, Amini A. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly. Semin Oncol. 2018;45(4):210–9.

Article  PubMed  Google Scholar 

Maeda R, Yoshida J, Ishii G, Aokage K, Hishida T, Nishimura M, Nishiwaki Y, Nagai K. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol. 2010;5(8):1246–50.

Article  PubMed  Google Scholar 

Yotsukura M, Muraoka Y, Yoshida Y, Nakagawa K, Shiraishi K, Kohno T, Yatabe Y, Watanabe SI. Long-term prognosis and prognostic indicators of stage IA lung adenocarcinoma. Ann Surg Oncol. 2023;30(2):851–8.

Article  PubMed  Google Scholar 

Murakami S, Ito H, Tsubokawa N, Mimae T, Sasada S, Yoshiya T, Miyata Y, Yokose T, Okada M, Nakayama H. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma. Lung Cancer. 2015;90(2):199–204.

Article  PubMed  Google Scholar 

Hung JJ, Yeh YC, Jeng WJ, Wu KJ, Huang BS, Wu YC, Chou TY, Hsu WH. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival. J Clin Oncol. 2014;32(22):2357–64.

Article  PubMed  Google Scholar 

Subramanian M, McMurry T, Meyers BF, Puri V, Kozower BD. Long-term results for clinical stage IA lung cancer: comparing lobectomy and sublobar resection. Ann Thorac Surg. 2018;106(2):375–81.

Article  PubMed  PubMed Central  Google Scholar 

Poullis M. Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy. J Thorac Oncol. 2016;11(5):e64–5.

Article  PubMed  Google Scholar 

Du Y, Zhan C, Li M, Qiao T. Promising stereotactic body radiotherapy in NSCLC. J Thorac Oncol. 2020;15(10):e165–6.

Article  PubMed  Google Scholar 

Bei Y, Chen X, Raturi VP, Liu K, Ye S, Xu Q, Lu M. Treatment patterns and outcomes change in early-stage non-small cell lung cancer in octogenarians and older: a SEER database analysis. Aging Clin Exp Res. 2021;33(1):147–56.

Article  PubMed  Google Scholar 

Razi SS, Kodia K, Alnajar A, Block MI, Tarrazzi F, Nguyen D, Villamizar N. Lobectomy versus stereotactic body radiotherapy in healthy octogenarians with stage i lung cancer. Ann Thorac Surg. 2021;111(5):1659–65.

Article  PubMed  Google Scholar 

Tolwin Y, Gillis R, Peled N. Gender and lung cancer-SEER-based analysis. Ann Epidemiol. 2020;46:14–9.

Article  PubMed  Google Scholar 

Zuo Z, Zhang G, Song P, Yang J, Li S, Zhong Z, Tan Q, Wang L, Xue Q, Gao S, et al. Survival nomogram for stage IB non-small-cell lung cancer patients, based on the SEER database and an external validation cohort. Ann Surg Oncol. 2021;28(7):3941–50.

Article  PubMed  Google Scholar 

Mukherjee K, Davisson N, Malik S, Duszak R Jr, Kokabi N. National utilization, survival, and costs analysis of treatment options for stage I non-small cell lung cancer: a SEER-medicare database analysis. Acad Radiol. 2022;29(Suppl 2):S173–80.